Dr Shairoz Merchant is an experienced consultant medical oncologist with specialist expertise in the management of breast and lung cancers. She provides comprehensive, patient-centred oncology care, with a strong focus on developing individualised treatment plans that reflect each patient’s diagnosis, clinical needs and circumstances. Her approach is centred on clear communication and collaborative decision-making, helping patients and their families understand their care and treatment options.
Dr Merchant qualified in medicine from King’s College London before undertaking specialist training in medical oncology at Imperial College Healthcare NHS Trust. During her training and subsequent clinical career, she developed extensive experience in the diagnosis and management of a range of oncological conditions, with particular expertise in breast cancer, lung cancer and acute oncology.
Her clinical practice includes the use of systemic anti-cancer therapies for breast and lung cancers. She has experience in chemotherapy, immunotherapy and targeted treatments, working closely with other specialists as part of multidisciplinary teams to ensure care is appropriately planned and coordinated. She is also experienced in coordinating radiotherapy pathways where this forms part of a patient’s wider treatment plan.
Alongside her clinical practice, Dr Merchant has a strong academic and research background. She completed a PhD at Imperial College London focused on breast cancer imaging, specifically investigating PET imaging in pre-clinical and clinical models of cell death. This research provided her with specialist knowledge of advanced imaging techniques and their potential application within cancer research and clinical practice.
Dr Merchant continues to be actively involved in clinical research alongside her work with patients. Her academic experience complements her clinical practice and supports her interest in evidence-based cancer care and developments in oncology. She maintains an interest in advances in cancer diagnosis and treatment, particularly within breast and lung oncology, and in how emerging approaches can contribute to the ongoing development of patient care.
Education and professional development also form an important part of Dr Merchant’s work. She is involved in teaching and mentoring resident junior doctors, sharing her clinical knowledge and experience with colleagues undertaking medical training. Through this work, she contributes to the development of future clinicians and supports learning within the wider oncology team.
Dr Merchant also has an interest in improving public understanding of cancer, including raising awareness of early cancer detection and non-communicable diseases. She participates in educational conferences and community outreach activities, helping to provide clear and accessible information about cancer and its management.
Throughout her career, Dr Merchant has combined clinical practice, research and medical education. She works collaboratively with multidisciplinary teams and other healthcare professionals to support coordinated care for her patients. Her specialist experience in breast and lung cancers, together with her expertise in chemotherapy, immunotherapy and targeted treatments, enables her to provide evidence-based and personalised oncology care.
Dr Merchant remains committed to maintaining her knowledge of developments within medical oncology and applying current clinical evidence to her practice. Her combination of specialist oncology experience, academic research and involvement in medical education supports her approach to delivering compassionate, individualised care for patients undergoing cancer treatment.
Clinical Interests
Dr Merchant specialises in breast and lung oncology, with extensive expertise in chemotherapy, immunotherapy and targeted treatments for both cancer types. She has a particular clinical interest in early breast cancer, particularly in younger women.